Beyond Bone Remodeling: Denosumab's Multisystemic Benefits in Musculoskeletal Health, Metabolism, and Age-Related Diseases-A Narrative Review.

Biomedicines · 2025 · PMC11940544 · PMID 40149708

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The denosumab group showed a highly significant decrease in the fall risk score and significant improvements in grip strength, TUG test performance, and gait speed ( Table 8 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.